Zatrox-CV is a potent antibacterial combination of Cefuroxime 500mg and
Clavulanate 125mg, designed to effectively treat moderate to severe bacterial
infections caused by β-lactamase–producing organisms. Clavulanate enhances the efficacy of
Cefuroxime by overcoming bacterial resistance, ensuring broader antimicrobial coverage.
This formulation is commonly prescribed for respiratory tract infections, sinusitis,
bronchitis, pneumonia, urinary tract infections, and skin & soft tissue infections.
Zatrox-CV supports rapid symptom relief, improved bacterial eradication, and reduced relapse
rates, leading to better clinical outcomes and patient compliance.
Reviews
There are no reviews yet.